BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04199104-completion@plaintrial.com
DTSTAMP:20261029T024256Z
DTSTART;VALUE=DATE:20250331
SUMMARY:A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E708
 0/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-liga
 nd 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Nec
 k Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010) — esti
 mated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04199104
URL:https://plaintrial.com/trial/NCT04199104
END:VEVENT
END:VCALENDAR